Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway

This study was to analyze the effect of triptolide (TPL) on proliferation, apoptosis, and the relationship between TPL and the Janus kinase/signal transducer and activator of transcription signaling pathway in hepatoma cells. HepG2 cell line was selected as the experimental object and divided into c...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang Guanglian, Zhu Zhenxin, Sun Zhengang, Yang Zhiqi
Format: Article
Language:English
Published: De Gruyter 2025-01-01
Series:Open Life Sciences
Subjects:
Online Access:https://doi.org/10.1515/biol-2022-1018
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832570479349596160
author Wang Guanglian
Zhu Zhenxin
Sun Zhengang
Yang Zhiqi
author_facet Wang Guanglian
Zhu Zhenxin
Sun Zhengang
Yang Zhiqi
author_sort Wang Guanglian
collection DOAJ
description This study was to analyze the effect of triptolide (TPL) on proliferation, apoptosis, and the relationship between TPL and the Janus kinase/signal transducer and activator of transcription signaling pathway in hepatoma cells. HepG2 cell line was selected as the experimental object and divided into control, low-dose TPL, medium-dose TPL, and high-dose TPL group. The control group did not receive any drug treatment, while the low, medium, and high-dose groups were treated with TPL at concentrations of 0.02, 0.05, and 0.10 μM, respectively. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, flow cytometry, and western blot were used to detach the TPL effect and mechanism. The cell proliferation inhibition rate in each dose group of TPL was lower than that in the control group, and the inhibition rate of cell proliferation increased with the increase of TPL dose (P < 0.05). The apoptosis rate of TPL in each dose group was higher than that in the control group, and the apoptosis rate increased with the increase of TPL dose (P < 0.05). The expression of phosphorylated Janus kinase 1 (p-JAK1) and phosphorylated signal transducer and activator of transcription 3 (p-STAT3) protein in cells of each dose group of TPL was lower than that in the control group, and the expression of p-JAK1 and p-STAT3 protein decreased with the increase of TPL dose (P < 0.05). The apoptosis rate of 10 ng/mL transforming growth factor-beta + high-dose group was reduced than that in the high-dose group, and the expression of p-JAK1 and p-STAT3 protein was higher than that in the high-dose group (P < 0.05). The activity of B-cell lymphoma/leukemia-2-associated X protein (Bax) protein and cysteine aspartic acid protease (Caspase)-3/9 in TPL cells at each dose was raised than that in the control group, and the expression of B-cell lymphoma/leukemia-2 (Bcl-2) protein was decreased than that in the control group. With the increase of TPL dose, the activity of Bax protein and Caspase-3/9 increased, and the Bcl-2 protein decreased (P < 0.05). As an anti-liver cancer agent, TPL inhibits the proliferation of hepatocellular carcinoma cells and promotes apoptosis. The mechanism may involve inhibiting Janus kinase 1/signal transducer and activator of transcription 3 pathway and activation of apoptosis-related pathways.
format Article
id doaj-art-1e937913eae24d7fb38f26551903185c
institution Kabale University
issn 2391-5412
language English
publishDate 2025-01-01
publisher De Gruyter
record_format Article
series Open Life Sciences
spelling doaj-art-1e937913eae24d7fb38f26551903185c2025-02-02T15:44:51ZengDe GruyterOpen Life Sciences2391-54122025-01-0120135935710.1515/biol-2022-1018Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathwayWang Guanglian0Zhu Zhenxin1Sun Zhengang2Yang Zhiqi3Department of Hepatobiliary Pancreatic and Splenic Surgery, Jingzhou Central Hospital, Jingzhou434020, Hubei, ChinaDepartment of Hepatobiliary Pancreatic and Splenic Surgery, Jingzhou Central Hospital, Jingzhou434020, Hubei, ChinaDepartment of Hepatobiliary Pancreatic and Splenic Surgery, Jingzhou Central Hospital, Jingzhou434020, Hubei, ChinaDepartment of Hepatobiliary Pancreatic and Splenic Surgery, Jingzhou Central Hospital, Jingzhou434020, Hubei, ChinaThis study was to analyze the effect of triptolide (TPL) on proliferation, apoptosis, and the relationship between TPL and the Janus kinase/signal transducer and activator of transcription signaling pathway in hepatoma cells. HepG2 cell line was selected as the experimental object and divided into control, low-dose TPL, medium-dose TPL, and high-dose TPL group. The control group did not receive any drug treatment, while the low, medium, and high-dose groups were treated with TPL at concentrations of 0.02, 0.05, and 0.10 μM, respectively. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, flow cytometry, and western blot were used to detach the TPL effect and mechanism. The cell proliferation inhibition rate in each dose group of TPL was lower than that in the control group, and the inhibition rate of cell proliferation increased with the increase of TPL dose (P < 0.05). The apoptosis rate of TPL in each dose group was higher than that in the control group, and the apoptosis rate increased with the increase of TPL dose (P < 0.05). The expression of phosphorylated Janus kinase 1 (p-JAK1) and phosphorylated signal transducer and activator of transcription 3 (p-STAT3) protein in cells of each dose group of TPL was lower than that in the control group, and the expression of p-JAK1 and p-STAT3 protein decreased with the increase of TPL dose (P < 0.05). The apoptosis rate of 10 ng/mL transforming growth factor-beta + high-dose group was reduced than that in the high-dose group, and the expression of p-JAK1 and p-STAT3 protein was higher than that in the high-dose group (P < 0.05). The activity of B-cell lymphoma/leukemia-2-associated X protein (Bax) protein and cysteine aspartic acid protease (Caspase)-3/9 in TPL cells at each dose was raised than that in the control group, and the expression of B-cell lymphoma/leukemia-2 (Bcl-2) protein was decreased than that in the control group. With the increase of TPL dose, the activity of Bax protein and Caspase-3/9 increased, and the Bcl-2 protein decreased (P < 0.05). As an anti-liver cancer agent, TPL inhibits the proliferation of hepatocellular carcinoma cells and promotes apoptosis. The mechanism may involve inhibiting Janus kinase 1/signal transducer and activator of transcription 3 pathway and activation of apoptosis-related pathways.https://doi.org/10.1515/biol-2022-1018triptolidejak/stat pathwayhepatoma cellsproliferationapoptosis
spellingShingle Wang Guanglian
Zhu Zhenxin
Sun Zhengang
Yang Zhiqi
Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
Open Life Sciences
triptolide
jak/stat pathway
hepatoma cells
proliferation
apoptosis
title Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
title_full Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
title_fullStr Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
title_full_unstemmed Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
title_short Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
title_sort mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting jak stat pathway
topic triptolide
jak/stat pathway
hepatoma cells
proliferation
apoptosis
url https://doi.org/10.1515/biol-2022-1018
work_keys_str_mv AT wangguanglian mechanismoftriptolideregulatingproliferationandapoptosisofhepatomacellsbyinhibitingjakstatpathway
AT zhuzhenxin mechanismoftriptolideregulatingproliferationandapoptosisofhepatomacellsbyinhibitingjakstatpathway
AT sunzhengang mechanismoftriptolideregulatingproliferationandapoptosisofhepatomacellsbyinhibitingjakstatpathway
AT yangzhiqi mechanismoftriptolideregulatingproliferationandapoptosisofhepatomacellsbyinhibitingjakstatpathway